|
1705301 |
Ubidecarenone (200 mg) |
[303-98-0] |
0.999 mg/mg (ai) |
|
1705323 |
Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9) |
[303-97-9] |
- |
|
1705312 |
Ubidecarenone for System Suitability (25 mg) |
[303-98-0] |
|
|
1705505 |
Undecylenic Acid (200 mg) |
[112-38-9] |
|
|
1705800 |
Uracil Arabinoside (50 mg) |
[3083-77-0] | - |
|
1706009 |
Uracil Mustard (500 mg) (FOR U.S. SALE ONLY) |
[66-75-1] |
|
|
1706698 |
Urea (200 mg) |
[57-13-6] |
1.00 mg/mg (ai) |
|
1706701 |
Urea C 13 (100 mg) |
[58069-82-2] |
0.999 mg/mg (dr) |
|
1707806 |
Ursodiol (125 mg) |
[128-13-2] |
|
|
1707908 |
Valerenic Acid (15 mg) |
[3569-10-6] |
1.00 mg/mg (ai) |
|
1708503 |
L-Valine (200 mg) |
[72-18-4] |
1.00 mg/mg (dr) |
|
1708707 |
Valproic Acid (500 mg) |
[99-66-1] |
0.998 mg/mg (ai) |
|
1708729 |
Valproic Acid Related Compound A (0.25 mL) (diallylacetic acid) |
[99-67-2] |
- |
|
1708718 |
Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) (AS) |
[62391-99-5] |
- |
|
1708762 |
Valsartan (350 mg) |
[137862-53-4] |
0.997 mg/mg (an) |
|
1708773 |
Valsartan Related Compound A (10 mg) ((R)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)-biphen-4-yl]-methyl)-valine) |
n/f |
0.96 mg/mg (ai) |
|
1708795 |
Valsartan Related Compound C (10 mg) ((S)-N-Valeryl-N-([2'-(1-H-tetrazole-5-yl)biphenyl-4-yl]-methyl)valine benzyl ester) |
n/f |
0.99 mg/mg (ai) |
|
1709007 |
Vancomycin Hydrochloride (4 vials, each vial contains 100,500 mcg of vancomycin activity) |
[1404-93-9] |
- |
|
1709018 |
Vancomycin B with Monodechlorovancomycin (350 mg) |
n/f |
0.81 mg/mg (an) |
|
1710006 |
Vanillin (200 mg) |
[121-33-5] |
- |
|
1711009 |
Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) |
[121-33-5] | - |
|
1711155 |
Vecuronium Bromide (50 mg) |
[50700-72-6] |
|
|
1711166 |
Vecuronium Bromide Related Compound A (25 mg) (3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan) |
n/f |
|
|
1711202 |
Verapamil Hydrochloride (200 mg) |
[152-11-4] |
0.999 mg/mg (dr) |
|
1711304 |
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monoHydrochloride) |
n/f |
|
|
1711406 |
Verapamil Related Compound B (50 mg) (alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile monoHydrochloride) |
[1794-55-4] |
|
|
1711428 |
Verapamil Related Compound D (50 mg) (5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile] hydrochloride) |
[190850-50-1] |
- |
|
1711461 |
Verteporfin (200 mg) |
[129497-78-5] |
|
|
1711472 |
Verteporfin Related Compound A (50 mg) ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid) |
n/f |
|
|
1711508 |
Vidarabine (200 mg) |
[24356-66-9] |
939 ug/mg (ai) |
|
1713004 |
Vinblastine Sulfate (50 mg) |
[143-67-9] |
|
|
1714007 |
Vincristine Sulfate (50 mg) |
[2068-78-2] |
0.996 mg/mg (dr) |
|
1714506 |
Vinorelbine Tartrate (200 mg) |
[125317-39-7] |
0.994 mg/mg (an) |
|
1714528 |
Vinorelbine Related Compound A (25 mg) (4-O-Deacetylvinorelbine tartrate) |
n/f |
|
|
1715000 |
Viomycin Sulfate (200 mg) |
[37883-00-4] |
|
|
1716002 |
Vitamin A (10 ampules containing vitamin A acetate in peanut oil) |
[127-47-9] |
- |
|
1717504 |
Vitamin D Assay System Suitability (1.5 g) |
[67-97-0] |
- |
|
1717708 |
Vitexin (30 mg) |
[3681-93-4] |
|
|
1719000 |
Warfarin (200 mg) |
[81-81-2] |
|
|
1719102 |
Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) |
[37209-23-7] |
- |
|
1720000 |
Xanthanoic Acid (100 mg) |
[82-07-5] |
|
|
1720203 |
Xanthone (100 mg) |
[90-47-1] |
|
|
1720407 |
Xylazine (200 mg) |
[7361-61-7] |
- |
|
1720429 |
Xylazine Hydrochloride (200 mg) |
[23076-35-9] |
|
|
1720600 |
Xylitol (1 g) |
[87-99-0] |
|
|
1721002 |
Xylometazoline Hydrochloride (125 mg) |
[1218-35-5] |
|
|
1722005 |
Xylose (1 g) |
[58-86-6] |
|
|
1724000 |
Yohimbine Hydrochloride (200 mg) |
[65-19-0] |
|
|
1724306 |
Zalcitabine (200 mg) |
[7481-89-2] |
|
|
1724317 |
Zalcitabine Related Compound A (50 mg) (2',3'-Didehydro-2',3'-dideoxycytidine) |
[7481-88-1] |
|
|
1724500 |
Zidovudine (400 mg) |
[30516-87-1] |
0.990 mg/mg (ai) |
|
1724521 |
Zidovudine Related Compound B (25 mg) (3'-chloro-3'-deoxythymidine) |
[25526-94-7] | - |
|
1724532 |
Zidovudine Related Compound C (100 mg) (thymine) |
[65-71-4] |
|
|
1724656 |
Zileuton (150 mg) |
[111406-87-2] |
|
|
1724667 |
Zileuton Related Compound A (50 mg) (N-(1-Benzo[b]thien-2-ylethyl) urea) |
n/f |
|
|
1724678 |
Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene) |
n/f |
|
|
1724689 |
Zileuton Related Compound C (50 mg) (1-Benzo[b]thien-2-ylethanone) |
n/f |
|
|
1724747 |
Zinc Oxide (2 g) (AS) |
[1314-13-2] |
99.7% (ig) |
|
1724769 |
Zinc Sulfate (1 g) (AS) |
[7446-20-2] |
56.4% (ai) |
|
1724805 |
Zolazepam Hydrochloride (500 mg) |
[33754-49-3] |
|
